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Abstract.  Human erythrocytes contain a Mr 43,000 
tropomyosin-binding protein that is unrelated to actin 
and that has been proposed to play a  role in modulat- 
ing the association of tropomyosin with spectrin-actin 
complexes based on its stoichiometry in the membrane 
skeleton of one Mr 43,000 monomer per short actin 
filament (Fowler, V.  M.  1987. J.  Biol.  Chem. 
262:12792-12800).  Here, we describe an improved 
procedure to purify milligram quantities to 98 % 
homogeneity and we show that this protein inhibits 
tropomyosin binding to actin by a novel mechanism. 
We have named this protein tropomodulin.  Unlike 
other proteins that inhibit tropomyosin-actin interac- 
tions,  tropomodulin itself does not bind to F-actin. 
EM of rotary-shadowed tropomodulin-tropomyosin 
complexes reveal that tropomodulin (14.5  +  2.4 nm 
[SD] in diameter) binds to one of the ends of the rod- 
like tropomyosin molecules (33 nm long).  In agree- 
ment with this observation, Dixon plots of inhibition 
curves demonstrate that tropomodulin is a non- 
competitive inhibitor of tropomyosin binding to 
F-actin (Ki  =  0.7/~M).  Hill plots of the binding of the 
tropomodulin-tropomyosin complex to actin indicate 
that binding does not exhibit any positive cooperativity 
(n  =  0.9),  in contrast to tropomyosin (n  =  1.9),  and 
that the apparent affinity of the complex for actin is 
reduced 20-fold with respect to that of tropomyosin. 
These results suggest that binding of tropomodulin to 
tropomyosin may block the ability of tropomyosin to 
self-associate in a head-to-tail fashion along the actin 
filament,  thereby weakening its binding to actin.  Anti- 
bodies to tropomodulin cross-react strongly with stri- 
ated muscle troponin I (but not with troponin T) as 
well as with a nontroponin Mr 43,000 polypeptide in 
muscle and in other nonerythroid cells and tissues, in- 
cluding brain,  lens, neutrophils,  and endothelial cells. 
Thus,  erythrocyte tropomodulin may be one member 
of a family of tropomyosin-binding proteins that func- 
tion to regulate tropomyosin-actin interactions  in non- 
muscle cells and tissues. 
T  ROPOMYOSINS in  nonmuscle  ceils  are  thought  to 
influence  actin  filament  assembly and  organization 
and to play a regulatory role in defining domains along 
actin  filaments,  based on in vitro biochemical experiments 
and on immunofluorescence localization  in cells. Tropomyo- 
sin blocks the interaction  of cross-linking  proteins such as 
filamin  or a-actinin  with actin  filaments  (47, 52,  65)  and 
tropomyosin-coated actin filaments are resistant  to bundling 
by villin (5), severing by gelsolin (16, 30, 52), and disassem- 
bly by actin-depolymerizing proteins (2, 46). Tropomyosin 
and t~-actinin are localized in a periodic,  alternating  fashion 
along actin filament bundles (stress fibers) in cultured cells 
(33, 35, 54) and tropomyosin is absent from actin filaments 
associated with cell junctions, attachment plaques and the 
foci of polygonal  networks in spreading  ceils with which 
tx-actinin is associated (26, 34). Similarly, villin is associated 
exclusively with the actin filament bundles in the microvilli 
of the intestinal epithelial  cell brush border, whereas tropo- 
myosin is associated with the bundle rootlets and actin ilia= 
ments in the terminal  web (45).  Evidence that tropomyosin 
functions  to regulate  actin filament  organization  in vivo is 
provided by disruption  of the single  tropomyosin gene in 
budding yeast which leads to disappearance of the character- 
istic cytoplasmic actin cables and reduced cell growth (37). 
Thus, modulation of tropomyosin-actin interactions  is ex- 
pected to be critical for the assembly, disassembly, and rear- 
rangements  of actin  filaments  that  take place during  cell 
locomotion, cell division, and differentiation related changes 
in cell shape. Previously described proteins from nonmuscle 
cells that can prevent the interaction  of tropomyosin with ac- 
tin and/or dissociate tropomyosin from actin do so by bind- 
ing to actin and competing for the same binding sites on actin 
filaments (5, 44). The ability of these proteins to influence 
the association of tropomyosin with actin is correlated with 
the relative affinities of these proteins and tropomyosin for 
F-actin.  For example,  a Mr 55,000  bundling  protein from 
HeLa cells induces the dissociation from actin of Mr 3,000- 
32,000 tropomyosin isotypes from cultured fibroblasts  that 
have a low affinity for actin but has little effect on the interac- 
tion with actin  of skeletal  muscle tropomyosin or the Mr 
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a high affinity for actin (45). In fact, skeletal muscle tropo- 
myosin reduces the ability of the Mr 55,000 bundling pro- 
tein itself to bind or bundle actin filaments. Proteins that bind 
directly to tropomyosin and independently influence tropo- 
myosin-actin interactions without themselves binding to ac- 
tin have not been described in nonmuscle cells. 
Troponins  I  and  T  are  tropomyosin-binding  proteins  in 
skeletal and cardiac muscle that are tightly associated with 
each other and with troponin C (the calcium-binding com- 
ponent)  in  a  troponin  complex.  One troponin  complex is 
associated with each tropomyosin molecule along the actin 
filaments in the muscle sarcomere and functions to confer 
calcium sensitivity on tropomyosin regulation of actomyosin 
ATPase activity. In vitro, binding of troponin promotes tropo- 
myosin head-to-tall  self-association and also enhances the 
binding of tropomyosin to actin.  Tropomyosin self-associa- 
tion along the actin filament is thought to be important for 
cooperative regulation of actomyosin ATPase during muscle 
contraction (for reviews, see references 8, 36, 49, 66). 
To  date,  tropomyosin-binding  proteins  homologous  to 
muscle troponins I or T have not been isolated from nonmus- 
cle cells and tissues. Instead,  a Ca2+-calmodulin-regulated 
F-actin  binding  protein,  caldesmon,  is  associated  with 
tropomyosin along the actin filaments of smooth muscle and 
nonmuscle cells and is thought to participate in thin filament 
regulation of actomyosin ATPase activity (for reviews see 
references 3, 43). Smooth muscle caldesmon also associates 
with tropomyosin (24, 27) and binding of caldesmon to actin 
is strengthened in the presence of tropomyosin (55, 57). Al- 
though nonmuscle caldesmon has not been reported to bind 
directly to tropomyosin, it enhances binding of nonmuscle 
tropomyosin isotypes to F-actin and is therefore proposed to 
play a role in regulation of actin filament organization in non- 
muscle cells (30, 65). 
We show here that a previously described Mr 43,000 tropo- 
myosin-binding  protein  (tropomodulin)  from  the  human 
erythrocyte membrane skeleton (19) is a potential candidate 
for a nonmuscle tropomyosin-regulatory protein based on its 
ability to bind to the end of tropomyosin and to inhibit tropo- 
myosin binding to actin in vitro. Tropomodulin is immuno- 
logically related to muscle troponin I, but is unrelated to cal- 
desmon, based  on  structural,  functional,  and  immunological 
criteria.  However, unlike  troponin  I and caldesmon, which 
bind to actin  and enhance tropomyosin binding to actin, 
tropomodulin itself  does not  bind  directly  to  actin.  This,  to- 
gether  with the identification of immunoreactive tropomodu- 
lin polypeptides in a variety of nonmuscle ceils and tissues 
indicates that erythrocyte tropomodulin may be a representa- 
tive of a new type of tropomyosin-regulatory protein in non- 
muscle cells. Modulation of tropomyosin-actin associations 
could  influence  actin  filament  organization  and  function 
and/or  actomyosin contractile  activity  in  nonmuscle  cells 
and tissues. 
Materials and Methods 
Membrane Preparation 
ErYthrocytes from 6 U of blood were isolated free of platelets,  leukocytes, 
and other white cells by sedimentation  at I g through 3.3 % gelatin in physio- 
logic saline and were obtained as a byproduct of neutmphil isolation from 
DIs. G. Bokoch, A. Jesaitis, and C. Cochrane (Department of Immunology, 
Research Institute of Scripps Clinic). The cells were washed four times in 
4 vol of 150 mM NaCI,  5 mM sodium phosphate, pH 7.4 to remove the 
gelatin and were stored overnight at 0oc in an ice bucket after addition to 
the packed cells of one-thonsandth volume of 200 mg/ml PMSF in DMSO. 
Packed cells were lysed by hypotonic hemolysis in 15 vol of 7.5 mM sodium 
phosphate, 1 mM EDTA, 2 mM DTT, 20 #g/ml PMSF, pH 7.4 at 4°C and 
membranes were prepared as previously described except that the cassette 
system (Pellican;  Millipore Corp., Bedford, MA) was equipped with 10 ft2 
of Durapore membrane (19). Membranes were collected by centrifugation 
overnight at 7,500 g (4°C), frozen in liquid nitrogen, and stored at -80°C. 
Approximately 300-350 ml of well-packed membranes (7-8 mg/ml protein) 
are obtained by this procedure from 6 U of blood. 
Purification of  Proteins 
Tropomodulin. Two batches of frozen membranes (600-700 ml,  12 U of 
blood) were combined and extracted  with ~'iton X-100 as described by 
Gardner and Bennett (25).  Triton X-100-extracted membranes were resus- 
pended to a final volume of 390 ml by homogenization  in the buffer used 
for hypotonic hemolysis (see above) and tropomoduiin was solubilized by 
addition of an equal volume of 1.6 M sodium bromide, 10 mM sodium phos- 
phate, 1 mM EDTA, 2 mM DTT, 20 #g/ml PMSF, pH 7.5. After incubation 
for 30 rain at 4°C, insoluble material was removed by centrifugation for 60 
rain at 235,000 g. The supematant was collected,  dialyzed into 20 m.M Tris, 
I mM EDTA, 2 mM DTT, pH 8.0 at 4°C, clarified by centrifugation for 
120 rain at 186,000 g, and loaded onto a  16  ×  1.5 em DEAE-cellulose 
(DE53; Whatman, Inc., Clifton, NJ) column equilibrated in the same buf- 
fer.  The column was  washed  with 5 column vol of this buffer and then 
ehited at 24 ml/h with 500 rnl of a linear NaCI gradient to 400 raM, collect- 
ing 4-ml fractions. Fractions containing  tropomodulin (ascertained by SDS- 
gel electrophoresis using a pH 9.1 separating gel [19]) eluted between 90 
and 120 mM NaC1 and were pooled and concentrated by addition of solid 
ammonium sulfate to 65 % saturation.  The precipitate was collected by cen- 
trifugation for 20 mill at 30,000 g, resuspended in 0.6 ml of 100 mM NaCI, 
20 mM Tris, 1 mM EDTA, 2 mM IYrT, 0.02% sodium azide,  pH 8.0 and 
dialysed overnight at 4°C against I liter of the same buffer. After centrifuga- 
tion for 20 rain at 150,000 g to remove aggregated material, the supernatant 
was loaded onto a 0.9 x  54 cm Ultrogel AcA 34 (Pharmacia-LKB Instru- 
ments, Gaithersburg, MD) gel filtration column and ehited at 2 ml/h in the 
same buffer, collecting 0.5 ml fractions. The tropomoduiin eluted in the sec- 
ond major protein peak (determined by A28o and SDS-gel electrophoresis 
of column fractions) and peak fractions were pooled and concentrated by 
vacuum dialysis  (Colloidion membranes; Schleicher &  Schuell,  Keene, 
NH) to a final volume of 0.5-0.8  ml. After dialysis overnight at 4°C into 
80 mM KCI, 20 mM Hepes, 0.1 mM EDTA, 2 mM DTT, 0.02%  sodium 
azide,  pH 7.3, the tropomodniin was centrifuged at 150,000 g. For rotary 
shadowing, tropomodniin was purified by an additional step of sedimenta- 
tion on a 5-20% linear sucrose gradient. Purified tropumodulin was stored 
at 0oc in an ice bucket for up to 1 mo before any proteolysis  or change in 
its properties was detectable. 
Dvpomyosin.  Membranes used for purification of erythrocyte tropo- 
myosin were prepared as described above, except that the lysis buffer con- 
tained 2 mM MgC12 and 1 mM EGTA instead of 1 mM EDTA (20). These 
membranes were lyophilized  and tropumyosin  was extracted and purified 
as described by Mak et al. (41) except that the lyophillzed membranes were 
preextracted with 0.1 M KC1, 1 mM EDTA, 20 mM Tris-HC1, 1 mM DTT 
for 60 rain at 0°C to remove magnesium before extracting the tropomyosin 
with.the 1.0 M KC1 buffer. For rotary shadowing, tropomyosin was purified 
by an additional  step of gel filtration over an Ultrogel AcA 34 gel filtration 
column in 1 M NaCI,  10 mM Tris, 0.1 mM EDTA, 2 mM DTT, 0.02% so- 
dium azide,  pH 8.0. 
Act/n. Rabbit skeletal muscle actin was prepared from an acetone pow- 
der of muscle by the method of Spudich and Watt (56) and further purified 
by gel filtration over an Ultrogel AcA 34 column as previously  described 
(20).  Actin was stored as monomer at -80oc and put through one cycle 
of polymerization and depolymerization before using in experiments. 
Tropon/ns. The tropunin complex was isolated from an acetone powder 
of rabbit skeletal muscle by high salt extraction and ammonium sulfate frac- 
tionation (51) followed by chromatography on hydroxylapatite  (14). Tropo- 
nins I  and T  were  purified  by  sequential  chromatography on  DEAE- 
cellulose (Whatman Inc.)  and CM-Sepharose CL-tB  (Pharmacla Fine 
Chemicals, Piscataway, NJ) in 6 M urea as described by Potter (51). 
Protein Concentrations 
The protein concentrations of erythrocyte tropomodulin, tropomyosin  and 
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precipitation with TCA as described by Fowler and Bennett (20), with bo- 
vine serum albumin as a standard. For very dilute gamples, 50 #g of tRNA 
(Escherichia coli, Strain B; Calbiocbem-Behring  Corp., La Jolla, CA) was 
added as a carrier. The protein concentration of monomeric actin was deter- 
mined from the absorbance at 290 um using an extinction coefficient  of 
0.617 cm2/g and corrected for light scattering by subtracting the absor- 
bance at 320 nm. 
Antibodies 
Tropomodulin.  Antibodies to tropomodulin were generated in rabbits by a 
primary injection  into the popliteal lymph nodes and into multiple intrader- 
real sites on the back of two  rabbits, with 35  #g of electrophoretically 
purified tropomodulin (in the gel slice) emulsified with CFA for each rabbit. 
Rabbits were boosted after 4 and after 8 wk by injections at multiple in- 
tradermal sites and in the subscapular area,  with 40 #g tropomodulin 
emulsified in incomplete Freund's adjuvant for each rabbit. Serum was col- 
lected 1, 2, and 3 wk after each boost, and antibody response was monitored 
by immunoblots. Antibodies were affinity purified as described by Burke 
et ai. (6) by adsorption and elution from 100 #g of purified tropomodulin 
that had been electrophoretically transferred to nitrocellulose (19). 
Troponins. Antibodies to rabbit skeletal muscle troponin I were affinity 
purified on a troponin I-Sepharose column (prepared according to instruc- 
tions from Pharmacia Fine Chemicals) from immune goat serum gener- 
ously supplied by Dr. Marion L. Greaser (University of Wisconsin, Madi- 
son, WI). Affinity-purified guinea pig antibodies to rabbit skeletal muscle 
troponin T were a gift from Dr.  Larry B. Smillie (University of Alberta, 
Edmonton, Canada). 
Actin-binding Assays 
Tropomyosin binding to F-actin was determined by measuring the amount 
of 125I-labeled tropomyosin cosedimenting with the F-actin. Tropomyosin 
was radioiodinated with l~I-labeled Bolton and Hunter reagent (New En- 
gland  Nuclear,  Boston,  MA)  and  the  protein  concentration (0.05-0.1 
mg/ml) and specific activity (2-3  ×  10  ~ cpm/#g) determined as previously 
described  (20).  The  F-actin  binding  properties  of  the  radioiodinated 
tropomyosin were identical to unlabeled tropomyosin in terms of apparent 
affinity and stoichiometry of binding (not shown), when used within 3--4 d 
of iodination and all of the radioiodine was associated  with troporoyosin, 
as determined by SDS-gel electrophoresis and autoradiography.  Before use 
in aetin-binding assays,  lzsI-tropomyosin  and tropomodulin were centri- 
fuged for 20 rain at 150,000 g at 4"C, and the actin was polymerized for 
2 h at 22°C by addition of 2 M KC1 to 80 mM and 0.1 M MgC12 to 2 raM. 
Tropomyosin  was mixed with F-actin (added using a Microman pipettor; 
Rainin Instrument Co., Woburn, MA) in the presence or absence of tro- 
pomodulin at the indicated concentrations in a  50-#1 assay volume in a 
buffer containing 80 mM KC1, 20 mM Hepes, 2 mM MgCI2, 2 mM DTT, 
10 mg/mi BSA, pH 7.3. Components were mixed directly in 250 #1 cen- 
trifuge tubes (model TLA 100; Beckman Instrument Co., FuUerton,  CA), 
incubated 90 rain at 25°C and centrifuged for 25 rain at 150,000 g in a rotor 
(TLA 100; Beckman Instruments). The supernatant was aspirated off using 
a vacuum aspirator and the amount of t2sI-tropomyosin  s~imenting was 
determined by counting the pellets (in the tubes) directly in a Beckman 
gamma counter.  The amount of 125I-tropomyosin bound to F-actin was cal- 
culated by subtracting the amount of 125I-tropomyosin sedimenting in the 
absence of F-actin for each concentration of tropomyosin,  which never 
amounted to >5 % of the t otai counts sedimenting in the presence of F-actin. 
The amount of F-actin sedimenting was determined independently in each 
assay by SDS-gel electrophoresis of supernatants and pellets as previously 
described (21), and was not influenced by the presence of tropomyosin  or 
tropomodulin (not shown). 
Electrophoresis Procedures 
SDS-gel electrophoresis was according to Laemmli (33), using 10% acryl- 
amide or 7.5-15%  linear gradient acrylamide gels with a 5% stacking gel 
except that a pH 9.1 or 8.6 separating gel was used to resolve tropomodulin 
from actin, as indicated in figure legends (see reference 20). Electrophoretic 
transfer of polypeptides from the SDS gels to nitrocellulose paper (0.2 #M; 
Schleicher &  Schuell,  Keene,  NH)  was  as  pnwiously  described  (20). 
Nitrocellulose gel transfers were pretreated before antibody labeling by in- 
cubation for 1 h in 150 mM NaCI,  10 mM sodium phosphate, pH 7.5 at 
65 °C (20). Transfers were labeled overnight  at 4"C on a rotating shaker with 
affinity-purified  antibodies (1-2 #g/mi) in a solution containing 150 mM 
NaC1, 10 mM sodium phosphate, 0.2% Triton X-100, 1 mM EDTA, 0.02% 
sodium azide and 40 mg/ml BSA, pH 7.5. To detect the goat anti-troponin 
I antibodies, transfers were subsequently incubated for 2 h at room tempera- 
ture with a 1/1,000 dilution of rabbit anti-goat antiserum in the same solu- 
tion. Blots were then washed five times each 2 rain at 4°C in the same buffer 
(without the serum albumin), and then labeled for 2 h at 4°C  with 106 
cpm/ml of 12~l-labcled protein A  (Staphylococcus aureus) in the same 
buffer without the serum albumin. Transfers were washed five times each 
2 rain, dried, and exposed at -80°C to film (X-AR; Eastman Kodak Co., 
Rochester,  NY) for autoradingraphy. 
Electron Microscopy 
To prepare samples for rotary shadowing,  proteins were dialysed for 1-2 h 
against two changes of 0.1 M ammonium acetate,  1 mM DTT, pH 7.0 in 
glass-distilled  water, and diluted to 5-10 #g/mi. Glycerol was added to a 
final concentration of 50-60%, samples were sprayed onto freshly cleaved 
mica, and rotary shadowed replicas were prepared by George Klier (La Jolla 
Cancer Research Foundation), using a tungsten filament with a twin-beam 
electron gun in an evaporator (Edwards High Vacuum, Inc., Grand Island, 
NY), as previously described (15). Replicas were examined at 75V with a 
Hitachi-600 electron microscope and photomicrographs taken by V. M. 
Fowler or G. Klier at magnifications  of 60,000 or 100,000. 
Results 
Purification of Tropomodulin 
Originally,  tropomodulin was purified  from a  1 M Tris ex- 
tract of tropomyosin-depleted  erythrocyte membranes (19). 
However, the yields of protein obtained by this procedure 
were poor (~,50 #g from 300 ml of membranes prepared 
from 2 U of blood), primarily due to inefficient extraction 
of the tropomodulin from the membranes. We have devised 
an improved purification procedure based on the observation 
that tropomodulin can be selectively and completely solubi- 
lized from membrane skeletons by incubation at 0°C with 
high concentrations  of the chaotropic salt, sodium bromide. 
This  procedure also solubilizes  ankyrin,  protein 4.9,  and 
other minor components,  without appreciably solubilizing 
spectrin,  proteins 4.1, 4.2, or actin (Fig.  1, lane c). Sodium 
chloride  is  not as  effective  at  solubilizing  tropomodulin, 
whereas substitution  of the iodide salt for the bromide solu- 
bilizes practically all  of the components of the membrane 
skeleton,  including  spectrin,  actin  and  protein  4.1  (not 
shown). 
The solubilized  protein is purified  from the sodium bro- 
mide extract  by adsorption to DEAE-cellulose and elution 
with a linear NaC1 gradient from 0 to 400 raM, followed by 
gel filtration  on Ultrogel AcA 34 (Fig.  1). At this stage the 
tropomodulin is ,~80-90% pure, depending  on the prepara- 
tion (Fig.  1,  lane f).  If more highly  purified  material  is 
desired,  the tropomodulin can be further purified to 98 % 
homogeneity by centrifugation  on a 5-20%  linear  sucrose 
gradient (not shown). Approximately 1.5-2 mg of tropomod- 
ulin are obtained from 600°700 ml of membranes isolated 
from 12 U of blood, which represents  a "o10-15 % yield with 
respect to the amount of tropomodulin present in the original 
membranes (estimated by quantitative immunoblotting  using 
purified tropomodulin as a standard). 
The amino acid composition of tropomodulin is character- 
ized by a low content of aromatic amino acids and a high 
proportion of acidic  residues (28.1%) (Table I), consistent 
with the pI of 5.1-5.2 determined from isolectric focusing 
gels in 9 M urea (not shown). Comparison of tropomodulin's 
amino acid composition with that of erythrocyte tropomyo- 
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erythrocyte membranes. Lane a, membranes (95/zg); lane b, Tri- 
ton X-100-extracted membranes (45/zg); lane c, NaBr-solubilized 
material from Triton-extracted membranes (DEAE-column load) 
(18 t~g); lanes d and e, pooled fractions from the DEAE-column 
(4 and 12 tzg, respectively); lane f, purified tropomodulin obtained 
from the Ultrogel AcA 34 column (8/~g). Tropomodulin was solu- 
bilized and purified from Triton X-100-extracted erythrocyte mem- 
branes as described in Materials and Methods. To compare the rela- 
tive amounts of tropomodulin in the starting membranes (lane a), 
Triton-extracted membranes (lane b) and the NaBr-solubilized ma- 
terial (lane c), samples were normalized to the original volume of 
the membranes and equivalent amounts electrophoresed on  10% 
acrylamide, pH 9.1 gels (19). The remaining samples were loaded 
to demonstrate presence (or absence) of contaminants. 
Table L Amino Acid Composition of  Human Erythrocyte 
Tropomodulin, Human Erythrocyte Tropomyosin, 
Rabbit Skeletal Muscle Actin, and Rabbit 
Skeletal Muscle Troponin I (Moles Percent) 
Human  Human  Rabbit  Rabbit skeletal 
Amino  erythrocyte  erythrocyte  skeletal  muscle 
acid  tropomodulin*  tropomyosin~:  muscle actin§  troponin I 
Asx  12.7  8.4  9.3  8.7 
Glx  15.4  27.6  10.6  16.9 
Ser  4.5  3.2  6.3  5.8 
Gly  4.6  2.2  7.6  4.3 
His  0.9  1.3  2.5  2.4 
Thr  4.8  3.4  7.7  1.9 
Ala  7.0  11.8  7.7  11.1 
Arg  5.3  9.5  4.9  9.7 
Pro  6.9  0  5.2  3.9 
Tyr  3.0  1.3  4.4  1.4 
Val  5.6  3.6  6.0  3.9 
Met  2.0  2.2  4.4  4.3 
Cys  0.6  ND  1.3  1.4 
Ile  4.1  4.1  7.9  2.4 
Leu  13.5  11.2  7.1  8.2 
Phe  1.7  0.5  3.3  1.4 
Lys  :  6.9  9.0  5.2  11.6 
Trp  ND  ND  1.1  0.5 
* Tropomodnlin was dialyzed versus 1 liter of 0.1  M  NaCI, 2  mM sodium 
phosphate, pH 7.5 and then versus three changes of 1 liter each deionized water 
(pH ,'~7.0) at 4°C. Samples were hydrolysed for 20-24 h at 110°C in 6 N HCI 
and anal~,zed on a high performance analyzer (model 6300;  Beckman Instru- 
ments) by Kerry Gwinn (Dr.  Tony Hugli's laboratory,  Research Institute of 
Scripps Clinic). Cysteine was determined as cysteic acid after performic acid 
oxidation. Values shown are the means from two replicate  analyses. 
:~ From Fowler and Bennett (20), 
§ Values calculated from the amino acid sequence for actin (7) and for rabbit 
fast muscle skeletal  troponin I (60). 
head at one end,  demonstrating that tropomodulin binds to 
one of the ends of the tropomyosin molecule (Fig. 4). In ex- 
amination  of >100  such  complexes,  rods  with  a  globular 
head  in  the  middle  or  on  both  ends  were never observed. 
sin,  rabbit skeletal muscle actin and rabbit skeletal muscle 
troponin I (see below) demonstrates that tropomodulin is dis- 
tinct  from any of these proteins  (Table I). 
Localization  of the Tropomodulin Binding Site 
on Tropomyosin 
In the electron microscope, erythrocyte tropomodulin mole- 
cules  visualized  after  rotary  shadowing  with  tungsten  and 
carbon are roughly globular in shape and somewhat heter- 
ogenous is size (Fig.  2).  Measurements of individual  parti- 
cles give a  mean diameter of 14.5  nm  -1- 2.4 nm (SD, n  = 
500),  with  some trailing  towards  the  low  end  of the  size 
range (not shown). In contrast, rotary shadowed erythrocyte 
tropomyosin  molecules  are  slender  rod-like  molecules, 
~33-34  nm  long  (Fig.  3).  This  length  is characteristic  of 
nonmuscle tropomyosins with native and subunit molecular 
weights  of  Mr  60,000  and  30,000,  respectively  (8,  49). 
Longer molecules (arrowheads) are presumed to represent 
end-to-end polymers of individual molecules, and are char- 
acteristic of tropomyosin from skeletal muscle (17) and from 
some nonmuscle cells  (16,  53). 
Electron  micrographs of rotary shadowed  tropomodulin- 
tropomyosin complexes show images of rods with a globular 
Figure 2.  Electron  micrograph  of rotary  shadowed  erythrocyte 
tropomOdulin  molecules.  Bar,  100 nm. 
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tropomyosin molecules. The arrowheads indicate examples of end- 
to-end polymers of tropomyosin. Bar, 100 nm. 
Some complexes appear to consist of an individual tropo- 
myosin molecule associated with tropomodulin (Fig. 4, left 
and middle columns),  whereas others appear to consist of 
end-to-end polymers of tropomyosin to which tropomodulin 
is bound (Fig. 4, right column). The rotary shadowed tropo- 
modulin-tropomyosin complexes also  exhibit considerable 
heterogeneity in the sizes of the tropomodulin molecules at- 
tached to  the  tropomyosin rods  (Fig.  4),  suggesting that 
tropomodulin may self-associate upon attachment to tropo- 
myosin (see Discussion). 
In some images, the globular tropomodulin head appears 
to be connected to the rod-like tropomyosin molecule by an 
extremely thin strand, or to be separated by a short gap (Fig. 
4, arrowheads).  In others, the length of the tropomyosin rod 
appears to be longer or shorter than 33-34 nm (Fig. 4, aster- 
isks).  Although we have not systematically quantitated these 
features, the variability in length of the rod portion of these 
complexes suggests that tropomodulin may be attached to 
tropomyosin by a short flexible domain, allowing the bulk of 
the tropomodulin molecule to extend away from the tropo- 
myosin, or alternatively to roll back onto the tropomyosin rod. 
Effect of Tropomodulin on Tropomyosin Binding 
to F-Actin 
Erythrocyte membrane tropomyosin, like other nonmuscle 
tropomyosins, binds to F-actin and spans between five and 
six actin monomers along the actin filament at saturation (20, 
41).  Because both tropomodulin and tropomyosin are as- 
sociated with the erythrocyte membrane skeleton (19), we 
expected  that  tropomodulin  would  bind  to  tropomyosin- 
coated actin filaments. To our surprise, inclusion of increas- 
ing amounts of tropomodulin dramatically reduced tropo- 
myosin binding to F-actin (Fig. 5 a). Tropomodulin is equally 
effective at inhibiting tropomyosin binding to F-actin whether 
or not the tropomyosin is preincubated with the F-actin be- 
fore addition of the tropomodulin (Table II), and tropomodu- 
lin itself does not bind to F-actin (Fig. 5 b). 
Figure 4. Electron micrographs of rotary shadowed tropomodulin- 
tropomyosin complexes. To form the complex, tropomodulin was 
mixed with tropomyosin in a 1:1 molar ratio (2.5 gM each protein) 
and incubated for 2 h at room temperature in a buffer consisting 
of 80 mM KC1, 1 mM MgC12, 1 mM DTT, 20 mM Hepes, pH 7.3. 
Samples  were  then  prepared  for  shadowing as  described  in 
Materials and Methods. Complexes in the left-hand column were 
more lightly shadowed than the complexes in the middle and fight- 
hand columns which were from another preparation.  Complexes 
grouped in the right-hand column appear to consist of an end-to- 
end  dimer  of tropomyosin (60-70  nm)  attached  to  a  globular 
tropomodulin molecule, whereas those grouped in the left and mid- 
dle columns appear to consist of a single tropomyosin rod attached 
to a globular tropomodulin molecule. Asterisks indicate examples 
of  complexes in the left and middle columns in which the tropomyo- 
sin rod portion appears to be shorter or longer than a single tropo- 
myosin molecule (33-34 ran), but not long enough to be an end-to- 
end dimer of tropomyosin, as in the far right column. Arrowheads 
indicate examples of a  thin  strand or short gap connecting the 
globular tropomodulin head to the tropomyosin rod. Bar, 50 rim. 
To examine the mechanism whereby tropomodulin inhibits 
tropomyosin binding to F-actin,  a  series of tropomodulin- 
inhibition curves were generated at several different concen- 
trations  of tropomyosin.  A  Dixon plot (12)  of these data 
demonstrates that tropomodulin is a non-competitive inhibi- 
tor of tropomyosin binding to F-actin with a Ki of 0.7 #M 
(Fig. 6), similar to the Kd for tropomyosin binding to tropo- 
modulin (0.5 gM, see ref. 19). This implies that tropomodulin 
binds to a site on tropomyosin distinct from the actin-binding 
sites that are located along the length of the tropomyosin rod 
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of Components on Tropomodulin Inhibition 
of Tropomyosin Binding to F-Actin 
Condition  TM bound 
A  TM  +  F-actin (90 m/n) 
B  TM  +  F-actin (45 rain) 
C  TM  +  F-actin (45 min)  +  Tmod (45 rain) 
D  TM  +  Tmod (45 min)  +  F-actin (45 min) 
mol/mol 
actin monomer 
0.023  100 
0.018  78 
0.006  26 
0.005  22 
(A and B) t25I-Bolton  Hunter  labeled  tropomyosin  (TM) (1.03 x  105 cpml#g; 
0.4 #M) was incubated  with rabbit skeletal muscle  F-actin  (4.0 #M) for 45 or 
90 rain, and the amount of ~25I-tropomyosin  binding  to F-actin was deter- 
mined as described in Materials and Methods. In C,  nsI-tropomyosin  was 
preincubatod with F-actin  before addition  of tropomodulin  (Tmod) (2.0 #M) 
and in D, ]~I-tropomyosin  was preincubated  with tropomodulin  before addi- 
tion of the F-actin. 
Figure  5.  Effect of purified tropomodulin on binding of human 
erythrocyte  tropomyosin to muscle F-actin. (A) Inhibition of t25I- 
labeled tropomyosin  binding to F-actin by increasing concentra- 
tions  of tropomodulin,  nSI-Bolton  Hunter-labeled tropomyosin 
(8.31  ×  104 cpm/#g, 1.0 #M) was incubated with muscle F-actin 
(2.0 #M) and varying amounts of tmpomodulin, and the amount of 
~I-tropomyosin binding to F-actin was determined as described 
in Materials and Methods.  (B) SDS-gels of supernatants (S) and 
pellets (P) from mixtures of(a) tropomodulin  and tropomyosin (un- 
labeled), (b) tropomyosin and F-act.in, (c) tropomodulin, tropomyo- 
sin, and F-actin. Components were  mixed and incubated as de- 
scribed in Materials and Methods  (final concentrations of 2.0 #M 
for tropomodulin, 1.1 #M for tropomyosin, and 4.0 #M for F-actin) 
and agrees with the morphological localization of the tropo- 
modulin binding site to the end of tropomyosin (Fig. 4). 
To estimate the affinity of the tropomodulin-tropomyosin 
complex for F-actin, a binding curve for tropomyosin bind- 
ing to F-actin was measured in the presence of  a large excess 
of tropomodulin (8 #M) (Fig. 7 a). This amount of tropo- 
modulin was sufficient to saturate the tropomyosin because 
further increases in the amount of tropomodulin caused no 
further reduction in the amount of tropomyosin bound to 
F-actin (not shown, but see Fig. 5 a). Hill plots (29) of the 
tropomyosin binding curves in the presence and absence of 
tropomodulin (Fig. 7 b) show that the apparent affinity  of  the 
tropomodulin-tropomyosin complex for F-actin is reduced 
20-fold (K, =  1.0  x  105 M -~) compared with that of trope- 
myosin for F-actin (K, =  1.9  x  106 M-~). The Hill plots of 
these binding curves also demonstrate that binding of the 
tropomodulin-tropomyosin complex to F-actin does not ex- 
hibit any positive  cooperativity (n  =  0.9)  in  contrast to 
tropomyosin (n  =  1.9).  This suggests that, unlike erythro- 
cyte tropomyosin, the tropomodulin-tropomyosin complex 
is incapable of self-association along the actin filament (see 
Discussion). 
Immunological Relationship of Tropomodulin to 
Muscle Troponin I 
Affinity-purified rabbit  antibodies  to  purified  erythrocyte 
tropomodulin are monospecific for tropomodulin on immu- 
noblots of erythrocyte membrane proteins (Fig.  8 B, lane a). 
These antibodies  cross-react  strongly  with purified  rabbit 
skeletal  muscle troponin  I  (Fig.  8  B,  lane  d)  and with  a 
comigrating  Mr 22,000 polypeptide in  extracts of rat stri- 
ated muscle (diaphragm) Fig.  8 B, lane e).  The Mr 22,000 
polypeptide in rat muscle indeed appears to be rat troponin 
except with the omission of the bovine serum albumin  and in a final 
volume of 75 #1. After centrifugation, superuatants were removed, 
precipitated,  and  solubilized for  SDS-gel  electrophoresis 
along with the pellets.  Equivalent amounts of superuatants and 
pellets  were electrophoresed  on 7.5-15%  linear gradient, pH 9.1 
acrylamide gels (19). In this experiment, '~50% of the tropomyosin 
cosediments with the F-actin  and tropomodulin  reduces this amount 
to approximately  10%,  as determined by pyridine elution of dye 
from the Coomassie blue stained bands (20). 
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Figure 6. Dixon plot (12) of inhibition of binding of 125I-erythro- 
cyte membrane tropomyosin to muscle F-actin in the presence of 
increasing concentrations of purified tropomodulin. Binding of 0.4 
(e), 0.6 (=), and 0.8 (A) pM 125I-tropomyosin  (1.27 x  105 cpm/ 
gg) to F-actin (4.0 #M) was determined in the presence of various 
concentrations of unlabeled tropomodulin, as described in Mate- 
rials and Methods. 
I since it is also labeled with afffinity-purified  antibodies to 
rabbit skeletal troponin I (Fig. 8 C, lane e). A relationship 
between tropomodulin and troponin I  is further indicated 
since antibodies to troponin I also cross-react (albeit rather 
weakly) with purified erythrocyte tropomodulin (Fig. 8 C, 
lane b). In contrast, antibodies to tropomodulin do not cross- 
react at all with purified rabbit skeletal muscle troponin T 
(Fig. 8 B, lane c), and conversely, antibodies to rabbit tropo- 
nin T do not cross-react with tropomodulin (Fig. 8 D, lane b). 
Anti-tropomodulin  antibodies  also  cross-react  strongly 
with a set of polypeptides in rat striated muscle that approxi- 
mately comigrate with erythrocyte tropomodulin (Fig. 8 B, 
lane e).  Like erythrocyte tropomodulin (19), the apparent 
mobility of these immunoreactive polypeptides on SDS-gels 
is inversely dependent on the pH of the separating gel buffer; 
Mr 45,000 at pH  8,-6 (Fig.  8),  Mr 43,000  at pH  8.8  (not 
shown), and Mr 39,000 at pH 9.1 (Fig. 9, lane 4). t Interest- 
ingly, antibodies to troponin I also cross-react weakly with 
a similar (the same?) set of Mr ,~45,000 polypeptides in rat 
muscle (Fig. 8 C, lane e). These polypeptides do not comi- 
grate with rat muscle troponin T on pH 8.6 gels (Fig. 8 D, 
lane e), or gels run at any other pH (not shown). Thus, stri- 
ated muscle appears to contain tropomodulin-like protein(s) 
that are immunologically related yet distinct from authentic 
troponin I. We are currently purifying and characterizing the 
putative muscle tropomodulin analogue(s) as well as cloning 
and sequencing cDNAs for erythrocyte  tropomodulin to pur- 
sue these questions. 
I. Unless noted otherwise, the apparent mobility (Mr) of tropomodulin on 
SDS gels (43,000) is as determined  using a standard Laemmli separating 
gel with a pH of 8.8 (32). 
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Figure 7.  (A) Binding of 125I-erythrocyte  tropomyosin to muscle 
F-aetin in the absence (e) or presence (o) of excess tropomodulin. 
(B) Hill plot  (29) of the data presented  in A.  ~25I-tropomyosin 
(5.35  x  104 epm/pg)  at the indicated concentrations was prein- 
cubated with (o) or without (e) tropomodulin (8.0 ttM) for 1 h at 
25"C before addition of muscle F-actin (2.0 #M) (final concentra- 
tions) and the amount of t2sI-tropomyosin  binding to F-actin was 
determined as described in Materials and Methods. In B, the bind- 
ing.data were plotted according to the Hill equation (29); log (ill-f) 
versus log free tropomyosin concentration, wherefis the fraction 
of binding sites on F-aetin that are occupied by tropomyosin. The 
total number of sites was estimated from the saturation point of the 
tropomyosin binding curve (e) in A. 
Immunoreactive Tropomodulin Polypeptides in 
Nonmuscle Cells and Tissues 
Polypeptides that comigrate with erythrocyte tropomodulin 
and cross-react with  antibodies to tropomodnlin are also 
present in rat brain and bovine endothelial cells (Fig. 9, lanes 
5 and 6), as well as in rat liver, ileum, kidney and bovine 
lens (not shown). These cross-reactive polypeptides also ex- 
hibit  a  pH-dependent  mobility  shift  on  SDS  gels  (not 
Fowler Regulation of Tropomyosin-Actin Associations  477 Figure 8. Immunological relationship of erythrocyte tropomodulin and muscle troponins. Samples of human erythrocyte membranes (lane 
a), erythrocyte tropomodulin (lane b), troponin T from rabbit skeletal muscle (lane c), troponin I from rabbit skeletal muscle (lane d), 
and rat striated muscle (diaphragm) (lane e) were electrophoresed on a 7.5-15  % acrylamide linear gradient, pH 8.6 gel and either stained 
with Coomassie blue (A) or electrophoretically transferred to nitrocellulose paper and labeled with affinity-purified  antibodies to erythrocyte 
tropomodulin (B), rabbit skeletal muscle troponin I (C), or rabbit skeletal muscle troponin T (D) as described in Materials and Methods. 
Amounts of proteins were 40 #g of erythrocyte membranes in A and 4 #g in B; 2.0 #g each of purified tropomodulin, troponin I, and 
troponin T in A and 0.2 #g each in B, C, and D; ,o60/~g of rat diaphragm muscle in all panels. All blots were exposed to x-ray film 
for the same amount of time (3 h). 
shown). In platelets and neutrophils, this comigrating poly- 
peptide is  barely detectable and  could be explained by a 
small amount of contaminating erythrocytes (Fig. 9, lanes 2 
and  3).  However, antibodies  to  tropomodulin also  cross- 
react with Mr 70,000 polypeptides in human neutrophils as 
well as in bovine endothelial cells (Fig. 9, lanes 2 and 6) and 
with Mr 27,000-28,000 polypeptides in rat brain and bovine 
endothelial cells (Fig.  9,  lanes 5  and 6).  5 Preinunune IgG 
does not label any of these polypeptides. These results sug- 
gest that tropomodulin may be one member of a  family of 
related tropomyosin-binding proteins present in both muscle 
and nonmuscle cells and tissues.  Experiments are in prog- 
ress to determine whether any of these cross-reactive poly- 
peptides are also tropomyosin-binding proteins. 
2. The cross-reactive Mr 22,000 troponin I polypeptide in rat muscle is not 
evident in Fig. 9 because these gels were electrophoresed to obtain maxi- 
mum resolution of trolbomodulin from actin, which caused the troponin I 
to run off of the gel. 
Discussion 
We  describe  here  the  properties  of  a  novel  Mr  43,000 
tropomyosin-binding protein, tropomodulin, from the eryth- 
rocyte membrane skeleton that binds to the end of erythro- 
cyte tropomyosin and inhibits tropomyosin binding to F-actin 
without itself binding to F-actin. Tropomodulin is unrelated 
to  actin,  a  tropomyosin-binding  protein  with  a  similar 
subunit molecular weight, based on amino acid composition, 
hydrodynamic properties, pH-dependent mobility on SDS- 
gels, stoichiometry and site specificity for tropomyosin bind- 
ing, and inability to polymerize (this paper and see reference 
19).  Tropomodulin also appears to be distinct from caldes- 
mon, a Mr 70,000-80,000 tropomyosin-binding protein from 
nonmuscle cells (3), based on amino acid composition and 
molecular  weight  (this  paper),  lack  of heat  stability and 
inability to bind calmodulin (Fowler, V. M., unpublished ob- 
servations),  property of weakening  rather than enhancing 
tropomyosin binding to actin, and inability to bind to actin 
(this paper). Antibodies to tropomodulin do not cross-react 
The Journal of Cell Biology, Volume 111,  1990  478 Figure 9. Identification of immunoreactive erythrocyte tropomodulin polypeptides in selected non-erythroid cells and tissues. Lane 1, hu- 
man erythrocyte  ghosts; lane 2, human neutrophils;  lane 3, human platelets;  lane 4, rat striated muscle (diaphragm);  lane 5, rat brain; 
lane 6, bovine aorta endothelial cells. Outdated platelet-rich plasma was obtained from the Red Cross and platelets were freed of erythro- 
cytes by low-speed centrifugation and then washed twice with 0.9% NaCI, 0.3 % sodium citrate. Isolated human neutrophils were kindly 
supplied by Dr. John Curnutte (Scripps Research Institute), and cultured bovine aorta endothelial cells by Dr. Paul McNeil (Harvard Medi- 
cal School). Ceils and tissues were solubilized directly in SDS-sample buffer and ,,o50-100-#g amounts were electrophoresed on triplicate 
10% acrylamide,  pH 9.1 gels (19) and either stained with Coomassie blue (lejf), or transferred to nitrocellulose and labeled with atfinity- 
purified antibodies to tropomodulin (middle) or preimmune IgG (right), followed by 125I-Protein  A to detect the immunoreactive polypep- 
tides. 
with actin or caldesmon and conversely, antibodies to actin 
or caldesmon do not cross-react with erythrocyte tropomod- 
ulin (Fowler, V. M., unpublished data). Furthermore, com- 
parison of the sequences of two different 21- and 25-amino 
acid tryptic peptides from tropomodulin with the sequences 
of muscle and nonmuscle actins or smooth muscle caldes- 
mon reveals no significant homologies (not shown). 
Physical Properties of Tropomodulin 
Tropomodulin is  an acidic  (pI 5.1-5.2)  Mr  43,000  protein 
with  an  amino  acid  composition  unlike  other  previously 
characterized Mr 40,000-43,000  proteins (48).  In solution, 
tropomodulin appears to be an asymmetric monomer (f13~ 
=  1.5) with a Stokes radius of 3.9 nm and a sedimentation 
coefficient of 2.8 S (19).  These hydrodynamic data are sur- 
prising considering  the  roughly globular morphology and 
large size of rotary shadowed tropomodulin molecules (aver- 
age diameter =  14.5 nm [Fig. 2]). Assuming a shadow thick- 
ness of 2-3 nm,  3 and a volume per dalton of 1.3 A 3 (39a), 
a 14.5-nm spherical particle would be expected to have a mo- 
lecular mass on the order of 250,000-450,000  D. It is possi- 
ble that the buffer conditions used for adsorption of trope- 
modulin to mica followed by rotary shadowing leads to self- 
association and distortion of tropomodulin molecules, thus 
altering their true size and morphology. Additionally, in pre- 
liminary experiments we have observed that tropomodulin 
exhibits a concentration-dependent self-association to tetra- 
mers, based on chemical cross-linking of tropomodulin in 
solution by copper-phenanthroline catalysed oxidation (un- 
3.  Shadow thickness was estimated by subtracting the actual width of a 
tropomyosin molecule (2 nm, see reference 23)  from the apparent width 
measured for shadowed tropomyosin molecules. 
Fowler Regulation of Tropomyosin-Actin Associations  479 published observations). Alternative approaches to determine 
the molecular mass,  shape,  and association states of tropo- 
modulin (e.g., analytical ultracentrifugation,  laser light scat- 
tering)  will be required to definitively  reconcile these dis- 
parate observations. 
Interaction of Tropomodulin with Tropomyosin 
EM  of rotary  shadowed  tropomodulin-tropomyosin  com- 
plexes demonstrates clearly that tropomodulin binds to only 
one of the ends of the tropomyosin  rod, since we never see 
complexes with globular heads at both ends or in the middle 
(Fig.  4).  This morphological observation is in agreement 
with the conclusion from Dixon  plots (Fig.  6) that  tropo- 
modulin is a noncompetitive  inhibitor of tropomyosin bind- 
ing to actin,  binding to a site on tropomyosin distinct  from 
the actin-binding  sites located along the length of the tropo- 
myosin rod. The images  of rotary shadowed tropomyosin- 
tropomodulin complexes also show that tropomodulin does 
not bind to the head-to-tall  junction region of tropomyosin 
dimers (Fig. 4, right  column), suggesting that tropomodulin- 
tropomyosin  interactions  may be incompatible  with tropo- 
myosin self-association.  This idea is supported by Hill plots 
(Fig. 7 b) which show no evidence of positive cooperativity 
for tropomodulin-tropomyosin binding  to actin  and imply 
that the tropomodulin-tropomyosin complex is incapable of 
head-to-tall  self-association  along  the actin  filament  (also 
see below).  (Since  subsaturating  concentrations  of tropo- 
modulin were used to prepare the complexes in the experi- 
ment presented in Fig. 4, we would not expect that all tropo- 
myosin  molecules  would have  a  tropomodulin  molecule 
attached at one end.) 
Tropomyosin molecules are coiled-coil, alpha-helical par- 
allel dimers with the amino terminus  of each subunit at one 
end of the molecule and the carboxy terminus  at the other 
(8, 36, 49). We are currently investigating  whether tropo- 
modulin binds to the NH2- or COOH-terminal  end of trope- 
myosin. The variability in the lengths of tropomyosin rods in 
the rotary  shadowed tropomodulin-tropomyosin  complexes 
(Fig. 4) may mean that tropomodulin interacts with upstream 
portions of the tropomyosin  molecule in addition  to the ex- 
treme COOH-terminal end. 
Mechanism of Tropomodulin Inhibition of 
Tropomyosin Binding to F-Actin 
Differences  in the actin-binding  affinity of different tropo- 
myosin  isotypes are thought  to be due at least in part to 
differences in their ability to self-associate head-to-tall along 
the actin filament (8, 49). This is because binding of an in- 
dividual  tropomyosin  molecule to F-actin  is much weaker 
than binding of two or three contiguous  tropomyosin mole- 
cules, linked through contacts at their ends, to actin (58). Al- 
though it has been generally assumed that non-muscle tropo- 
myosins are incapable of head-to-tail self-association because 
they bind to F-actin more weakly than muscle tropomyosins 
(8,  49),  nonmuscle  tropomyosins  purified  from  different 
cells and tissues vary considerably in their  actin-binding 
affinity (4, 9, 20, 38, 53). In addition,  Pruliere et al.  (54) 
have  shown  directly  that  pig  platelet  tropomyosin  self- 
associates head-to-tall, using viscometry and negative stain- 
ing EM. 
Erythrocyte  tropomyosin  exists  as  homodimers  of Mr 
29,000 and 27,000 polypeptides, based on oxidative cross- 
linking experiments  (Fowler, V. M., unpublished data), and 
the Mr 27,000  tropomyosin  has a  higher  apparent  affinity 
and  lower Mg  :÷ requirement  for binding  to  F-actin  than 
does the Mr  29,000  tropomyosin (20).  The  actin-binding 
properties of the Mr 27,000 isoform more closely resemble 
those of muscle tropomyosin  (64), and binding  of erythro- 
cyte tropomyosin to F-actin is highly cooperative (Fig. 7 b, 
and  see reference  20), as is muscle tropomyosin  (58, 64), 
consistent  with the possibility that erythrocyte tropomyosin 
self-associates  along  the actin  filament.  Indeed, images of 
rotary shadowed molecules of erythrocyte tropomyosin  re- 
veal  numerous  examples  of end-to-end  polymers  of in- 
dividual  tropomyosin molecules (Fig.  3). 4 
In the presence of  excess tropomodulin, tropomyosin bind- 
ing to F-actin no longer exhibits any positive cooperativity 
(Hill coefficient  =  0.9) and its apparent affinity for F-actin 
is reduced by ,x,20-fold (Fig.  7 b). This,  together with the 
ability  of tropomodulin  to bind to the end of erythrocyte 
tropomyosin,  suggests that tropomodulin may weaken tropo- 
myosin-actin interactions  by interfering  with head-to-tail 
self-association  of tropomyosin along the actin filament. Al- 
ternatively, since recent experiments with recombinant tropo- 
myosins  indicate  that  ability to  self-associate  head-to-tail 
may not necessarily be linked  to cooperativity in F-actin 
binding  (29),  it is also conceivable that binding  of tropo- 
modulin to tropornyosin could induce a conformational change 
in the tropomyosin rod that results in a qualitative change in 
its interaction with F-actin, reducing both its binding affinity 
and cooperativity.  To evaluate these ideas,  it will be neces- 
sary to examine directly the effect of tropomodulin  on tropo- 
myosin self-association  in the absence of F-actin. 
Relationship of Tropomodulin to Muscle Troponin I 
The  immunological  cross-reactivity  between  erythrocyte 
tropomodulin and striated muscle troponin I (but not tropo- 
nin T) is surprising  (Fig.  8). Troponin  I is a basic (pI 9.3) 
Mr 20,000-24,000 protein which is tightly associated both 
with troponin C (the calcium-binding  component) and tropo- 
nin T in the troponin  complex (for reviews,  see references 
36, 66). Purified troponin I also binds to tropomyosin  (10, 
50) and strengthens the binding of both muscle (13) and non- 
muscle (equine platelet) (9) tropomyosins to F-actin. In con- 
trast,  tropomodulin  is  an  acidic  (pI  5.1-5.2)  Mr  43,000 
tropomyosin-binding  protein which weakens the binding of 
tropomyosin  to F-actin.  Furthermore,  troponin  I interacts 
directly  with  troponin  C,  as  well  as  with  calmodulin, 
whereas  we  have  been  unable  to  detect  any  binding  of 
tropomodulin to calmodulin  (Fowler,  V.  M.,  unpublished 
observations).  Troponin  I can also bind directly to F-actin 
in the absence of tropomyosin,  unlike tropomodulin (Fig. 5 
b). Moreover, the sequences of two different 21- and 25-amino 
acid tryptic peptides from tropomodulin do not exhibit any 
significant similarities  with the sequence of troponin  I (not 
shown). 
Together,  these  observations  suggest  that  any  potential 
similarity  between tropomodulin  and troponin  I  must be 
4. A previous report that erythroeyte tropomyosin is incapable of head-to- 
tail self-association using a viseometric assay (41) may be explained by the 
relative insensitivity of this assay, together with the threefold greater amount 
of the weaker aetin-binding Mr 29,000 isoform in purified preparations of 
erythrocyte tropomyosin (20). 
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tropomyosin-binding  domain(s). The presence of variable, 
isotype-specific sequences in the COOH-terminal  portion of 
muscle and non-muscle tropomyosin molecules (8, 40) could 
explain our previous observations that the muscle troponin 
complex is unable to compete for ~2q-tropomyosin binding 
to tropomodulin (19). Alternatively,  purified troponin I may 
interact differently  with erythrocyte  tropomyosin than does 
the intact troponin complex. 
Role of 1?opomodulin in the Erythrocyte 
Membrane Skeleton 
The human erythrocyte membrane skeleton consists of many 
short actin  filaments  (33-37  um long) cross-linked  into a 
strikingly regular hexagonal lattice by long, flexible spectrin 
molecules  (for  reviews  see  references  1,  18,  42).  Both 
tropomyosin and tropomodulin are components of the eryth- 
rocyte membrane skeleton and are present in stoichiometric 
amounts  with  respect  to  the  erythrocyte  actin  filaments 
(tropomodulin/tropomyosin/actin  filament  =  1:2:1) (19-21). 
The erythrocyte  tropomyosin molecules (33-34 nm) are al- 
most long enough to span the length of the short actin fila- 
ments, one on each strand of the filament  (in vitro,  tropo- 
myosin/actin =  1:5-6). Based on the ability of tropomyosin 
to inhibit purified spectrin binding to F-actin (21, 41), tropo- 
myosin was proposed to play a role in regulating  spectrin- 
actin interactions. In addition, tropomyosin was also proposed 
to play a role in mechanically stabilizing  the erythrocyte ac- 
tin filaments based on in vitro observations that tropomyosin- 
coated actin filaments are resistant to fragmentation  (59). 
The inhibitory effect of tropomodulin on tropomyosin-actin 
interactions is surprising considering the relative amounts of 
these components in the  erythrocyte  membrane skeleton. 
However,  at present there is no direct evidence that tropo- 
modulin is in fact associated with tropomyosin on the eryth- 
rocyte actin filaments. It is possible that in the mature eryth- 
rocyte, tropomodulin is sequestered from tropomyosin by its 
association with other membrane proteins so as not to inhibit 
tropomyosin binding to actin.  This is consistent with obser- 
vations that tropomodulin remains associated with the mem- 
brane  after extraction  of tropomyosin (19).  Therefore,  we 
speculate that tropomodulin may be bound to tropomyosin 
only in immature erythrocytes and function to regulate tropo- 
myosin-actin associations during erythroid  differentiation, 
for example during the massive reorganization of actin fila- 
ments that occurs during enucleation (31). Titration of tropo- 
myosin-actin  associations  by  limiting  amounts of tropo- 
modulin could potentially  result in selective disassembly of 
non-tropomyosin-coated actin  filaments  by actin  filament- 
fragmenting and/or depolymerizing proteins. We are explor- 
ing these ideas by characterizing  the interaction  of tropo- 
modulin with other erythrocyte  membrane proteins  and by 
examining the biosynthesis and assembly of tropomodulin, 
tropomyosin and actin in the membrane skeleton during ter- 
minal differentiation  of erythrocytes. 
Although tropomodulin is unlike  muscle troponin  I by 
numerous criteria  (see above),  the presence of myosin in 
erythrocytes  (22, 63) makes it conceivable that tropomodu- 
lin could be a functional  analogue of muscle troponin I and 
interact  with erythrocyte  tropomyosin to regulate  erythro- 
cyte actomyosin ATPase activity. If so, we would expect that 
additional  tropomyosin and/or tropomodulin binding corn- 
ponents  will be required  to confer calcium-sensitivity  on 
tropomyosin regulation of actomyosin ATPase since tropo- 
modulin-tropomyosin interactions are not calcium-sensitive 
(19).  In this regard,  it may be significant that erythrocytes 
have been recently reported to contain  a Mr 70,000 poly- 
peptide that cross-reacts specifically with antibodies to non- 
muscle caldesmon (11). 
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